Table 1 presents nine patients with 13 episodes of euDKA or ketosis in the setting of treatment with SGLT-2 inhibitors. Among these patients, three had repeat episodes of ketosis on rechallenge. None ...
Purpose: A rare adverse effect observed after dose escalation of topiramate therapy is discussed. A review of published cases, monitoring recommendations, and important counseling information for ...
The anion gap essentially refers to an estimate of unmeasured anions in the serum. In DKA, ketoacids are produced that ionize into hydrogen cations and ketoacid anions. These anions are not measured ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with type 1 diabetes presenting with symptoms ...
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with an almost 3-fold increased risk of diabetic ketoacidosis (DKA) in some patients with type 2 diabetes (T2D), according to data from ...
Background. A 36-year-old African American man with end-stage renal disease on chronic maintenance hemodialysis was transferred first from a hospital to a long-term acute care facility for advanced ...
Hyperglycemic hyperosmolar nonketotic syndrome (HHNS) is also known as hyperglycemic hyperosmolar syndrome (HHS). It involves very high blood sugar levels and can be life threatening. HHNS can happen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback